首页> 美国卫生研究院文献>Journal of Clinical Medicine >Characteristics of Older Adults Who Were Early Adopters of Medical Cannabis in the Florida Medical Marijuana Use Registry
【2h】

Characteristics of Older Adults Who Were Early Adopters of Medical Cannabis in the Florida Medical Marijuana Use Registry

机译:在佛罗里达医用大麻使用登记中是医用大麻早期采用者的老年人的特征

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Use of medical marijuana is increasing in the United States and older adults are the fastest growing user group. There is little information about the characteristics and outcomes related to medical marijuana use. This study is a descriptive analysis of older adults (aged ≥50 years old) who were early adopters of a medical marijuana program in the U.S. state of Florida. Per state legislation, initial and follow-up treatment plans were submitted to the University of Florida College of Pharmacy. Data collection included demographics, clinical history, medical conditions, substance use history, prescription history, and health status. Follow-up treatment plans noted changes in the chief complaint and actions taken since the initial visit. Of the state’s 7548 registered users between August 2016 and July 2017, = 4447 (58.9%) were older adults. Patients utilized cannabidiol (CBD)-only preparations (45%), preparations that had both tetrahydrocannabinol (THC) and CBD (33.3%) or were recorded to use both CBD-only and THC + CBD products (21.7%). The chief complaints indicating medical cannabis treatment were musculoskeletal disorders and spasms (48.4%) and chronic pain (45.4%). Among other prescription medications, patients utilized antidepressants (23.8%), anxiolytics and benzodiazepines (23.5%), opioids (28.6%), and cardiovascular agents (27.9%). Among all drug classes with potential sedating effects, 44.8% of the cohort were exposed to at least one. Patients with follow-up visits (27.5%) exhibited marked improvement as assessed by the authorizing physicians. However, the patient registry lacked detailed records and linkable information to other data resources to achieve complete follow up in order to assess safety or efficacy. Future improvements to registries are needed to more adequately capture patient information to fill knowledge gaps related to the safety and effectiveness of medical marijuana, particularly in the older adult population.
机译:在美国,医用大麻的使用正在增加,而老年人是增长最快的用户群体。关于与医用大麻使用有关的特征和结果的信息很少。这项研究是对美国佛罗里达州医疗大麻计划的较早采用者的老年人(≥50岁)进行的描述性分析。根据州立法,初步和后续治疗计划已提交给佛罗里达大学药学院。数据收集包括人口统计学,临床史,医疗状况,药物使用史,处方史和健康状况。后续治疗计划指出,自首次访问以来,主要投诉发生了变化,并采取了行动。 2016年8月至2017年7月,该州的7548名注册用户中,有4447名(58.9%)是老年人。患者使用仅含大麻二酚(CBD)的制剂(45%),同时具有四氢大麻酚(THC)和CBD(33.3%)的制剂或记录使用仅CBD的制剂和THC + CBD产品(21.7%)。表明医疗大麻治疗的主要投诉是肌肉骨骼疾病和痉挛(48.4%)和慢性疼痛(45.4%)。在其他处方药中,患者使用抗抑郁药(23.8%),抗焦虑药和苯二氮卓(23.5%),阿片类药物(28.6%)和心血管药物(27.9%)。在所有可能具有镇静作用的药物类别中,有44.8%的队列暴露于至少一种。经授权医生评估,随访患者(27.5%)表现出明显改善。但是,患者注册表缺少详细记录和可链接到其他数据资源的信息,无法进行完整的随访以评估安全性或有效性。需要对注册表进行进一步的改进,以更充分地捕获患者信息,以填补与医用大麻的安全性和有效性有关的知识空白,尤其是在成年人口中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号